Squarepoint
BIOA

Squarepoint’s BioAge Labs BIOA Stock Holding History

Squarepoint’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
68,436
+12,916
+23% +$233K ﹤0.01% 2478
2026
Q1 		$971K Buy
55,520
+4,247
+8% +$81.8K ﹤0.01% 2803
2025
Q4 		$678K Buy
+51,273
New +$454K ﹤0.01% 2948
2025
Q1 		– Sell
-12,263
Closed -$71K – 5578
2024
Q4 		$71K Sell
12,263
-24,051
-66% -$415K ﹤0.01% 4775
2024
Q3 		$755K Buy
+36,314
New +$728K ﹤0.01% 2817

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Squarepoint's BIOA Position: Q2 2026 in Review

Squarepoint increased its BioAge Labs (BIOA) stake by 23% in Q2 2026, buying an estimated $233K and bringing the position to 68,436 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2478.

Squarepoint first reported a position in BIOA in Q3 2024 and has held it in 5 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Squarepoint held 68,436 shares of BioAge Labs worth $1.68M as of Q2 2026.
  • Squarepoint bought 12,916 BioAge Labs shares in Q2 2026, an estimated $233K.
  • BioAge Labs made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2478 holding.
  • Squarepoint first reported a position in BioAge Labs in Q3 2024 and has held it in 5 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.